Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXW47Y
|
||||
| Drug Name |
((S)-3-Methyl-1-{2-[4-(pyridin-4-ylmethoxy)-phenylamino]-ethylcarbamoyl}-butyl)-carbamic acid benzyl ester
|
||||
| Synonyms |
CHEMBL61887
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C28H34N4O4
|
||||
| Canonical SMILES |
CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)NCCNc2ccc(OCc3ccncc3)cc2
|
||||
| InChI |
InChI=1S/C28H34N4O4/c1-21(2)18-26(32-28(34)36-20-22-6-4-3-5-7-22)27(33)31-17-16-30-24-8-10-25(11-9-24)35-19-23-12-14-29-15-13-23/h3-15,21,26,30H,16-20H2,1-2H3,(H,31,33)(H,32,34)/t26-/m0/s1
|
||||
| InChIKey |
BZXPVORDSGFJNN-SANMLTNESA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.